Vitamin E Supplement Decreases Autoantibodies To Oxidized LDL

November 11, 1998


DALLAS -- Antioxidants such as vitamin E can help control levels of autoantibodies associated with oxidized lipid-protein complexes, report Emory University researchers at this week's 71st Scientific Sessions of the American Heart Association.

Autoantibodies to oxidatively altered proteins are indicative of the harmful oxidation of low-density lipoprotein (LDL), a precursor to artery-clogging atherosclerosis. The team, led by Emory University's Sampath Parthasarathy, Ph.D., also reports that levels of such autoantibodies "might serve as an indicator for the efficacy of antioxidants to attenuate oxidation in vivo." Measurements taken in 21 women without atherosclerosis before and after eight weeks of vitamin E supplementation, indicated a significant decrease in autoantibodies associated with oxidation of lipoproteins.

First author of the study was Nalini Santanam, Ph.D., assistant professor of Gynecology and Obstetrics at the Emory University School of Medicine, and her Emory departmental colleagues Caroline Jonas, (graduate student in the Nutrition and Health Sciences Program) and Ana A. Murphy, M.D., and Dr. Parthasarathy, who is McCord-Cross Professor and director of research in Gynecology and Obstetrics, and professor of Medicine (Cardiology). The study was supported by the National Institutes of Health.
(Abstract APS 690.3 - "Vitamin E Supplementation Decreases Antibodies to Oxidized Lipid-protein Complexes." Nov. 11, 1998, 9 a.m.-Noon, Dallas Convention Center, Exhibit Hall - Santanam Nalini; Jones, Caroline: Murphy, Ana; Parthasarathy, Sampath.)

Media Contacts: Sarah Goodwin, 404-727-3366,
Kathi Ovnic, 404-727-9371,

Emory University Health Sciences Center

Related Atherosclerosis Articles from Brightsurf:

How hormone therapy slows progression of atherosclerosis
As one of the most common treatments for effectively managing menopause symptoms, hormone therapy (HT) is also known to provide multiple health benefits, including slowing the progression of atherosclerosis.

T cells can shift from helping to harming in atherosclerosis
At La Jolla Institute for Immunology (LJI) researchers are dedicated to finding a way to stop plaques from forming in the first place.

New nanoparticle drug combination for atherosclerosis
Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.

Atherosclerosis -- How a microRNA protects vascular integrity
Ludwig-Maximilian-Universitaet (LMU) in Munich researchers have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of atherosclerosis.

Atherosclerosis progresses rapidly in healthy people from the age of 40
A CNIC study published in JACC demonstrates that atheroma plaques extend rapidly in the arteries of asymptomatic individuals aged between 40 and 50 years participating in the PESA-CNIC-Santander study.

Scaling up a nanoimmunotherapy for atherosclerosis through preclinical testing
By integrating translational imaging techniques with improvements to production methods, Tina Binderup and colleagues have scaled up a promising nanoimmunotherapy for atherosclerosis in mice, rabbits and pigs -- surmounting a major obstacle in nanomedicine.

Bladder drug linked to atherosclerosis in mice
A drug used in the treatment of overactive bladder can accelerate atheroclerosis in mice, researchers at Karolinska Institutet in Sweden report in a study published in the Proceedings of the National Academy of Sciences (PNAS).

A new therapeutic target for blocking early atherosclerosis in progeria
Researchers at the Centro Nacional de Investigaciones Cardiovasculares and the Universidad de Oviedo have discovered a new molecular mechanism involved in the premature development of atherosclerosis in mice with Hutchinson-Gilford progeria syndrome.

Protective mechanism against atherosclerosis discovered
Immune cells promoting inflammation play a crucial role in the development of atherosclerosis.

Atherosclerosis: Stopped on time
For the first time, LMU researchers are pointing out the influence of the internal clock on atherosclerosis.

Read More: Atherosclerosis News and Atherosclerosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to